Repeated dexamphetamine treatment alters the dopaminergic system and increases the phMRI response to methylphenidate-Reference-Cited by-同舟云学术

Repeated dexamphetamine treatment alters the dopaminergic system and increases the phMRI response to methylphenidate

Published:2017-02-27 Issue:2 Volume:12 Page:e0172776
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Schrantee Anouk,Tremoleda Jordi L.,Wylezinska-Arridge Marzena,Bouet Valentine,Hesseling Peter,Meerhoff Gideon F.,de Bruin Kora M.,Koeleman Jan,Freret Thomas,Boulouard Michel,Desfosses Emilie,Galineau Laurent,Gozzi Alessandro,Dauphin François,Gsell Willy,Booij Jan,Lucassen Paul J.,Reneman Liesbeth

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference45 articles.

1. Amphetamine neurotoxicity: accomplishments and remaining challenges;UD McCann;Neurosci Biobehav Rev,2004

2. Amphetamine and its analogs;J Gibb,1994

3. Update on amphetamine neurotoxicity and its relevance to the treatment of ADHD;C Advokat;J Atten Disord,2007

4. Potential adverse effects of amphetamine treatment on brain and behavior: a review;SM Berman;Mol Psychiatry. Nature Publishing Group,2009

5. Amphetamine treatment similar to that used in the treatment of adult attention-deficit/hyperactivity disorder damages dopaminergic nerve endings in the striatum of adult nonhuman primates;GA Ricaurte;J Pharmacol Exp Ther,2005

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Methylphenidate cross-sensitization with amphetamine is dose dependent but not age dependent;Behavioural Brain Research;2023-02

2. Sensitization-based risk for substance abuse in vulnerable individuals with ADHD: Review and re-examination of evidence;Neuroscience & Biobehavioral Reviews;2022-04

3. Imaging of the dopamine system with focus on pharmacological MRI and neuromelanin imaging;European Journal of Radiology;2021-07

4. Amphetamine Induces Oxidative Stress, Glial Activation and Transient Angiogenesis in Prefrontal Cortex via AT1-R;Frontiers in Pharmacology;2021-05-03

5. Potential Role of Dexamphetamine in the Treatment of Non-alcoholic Fatty Liver Disease: Hopes and Pitfalls;European Endocrinology;2021